NFKB1 and leukemia: An important subset of responder genes (Gene set 1‐ downregulated anti‐apoptotic genes in leukemia) is associated with the NF‐κB signaling pathway (Figs 3B and 4; Table S1), which plays a fundamental role in the development of AML and represents an attractive target for therapeutic intervention [32, 33, 34].